Microbiologic purity of dialysate: Rationale and technical aspects

被引:37
作者
Canaud, B [1 ]
Bosc, JY [1 ]
Leray, H [1 ]
Morena, M [1 ]
Stec, F [1 ]
机构
[1] Lapeyronie Univ Hosp, Dept Nephrol, F-34295 Montpellier, France
关键词
dialysate purity; microbiology; hemocompatibility; inflammation hemodialysis;
D O I
10.1159/000014419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dialysate purity has become a major concern in hemodialysis since it has been shown that microbial-derived products were stimulating the production and the release of proinflammatory cytokines in hemodialysis patients. This chronic microinflammatory state induced by hemodialysis has been putatively implicated in the development of dialysis-related pathology. In order to prevent risk related to these offenders and to reduce patient/dialysis interaction, it appears highly desirable to use ultrapure dialysis fluid aiming at sterility and apyrogenicity on a regular basis. Ultrapure dialysate results from a complex chain of production where purity grade relies on the weaker link of this chain. Technical aspects and pitfalls in the production of ultrapure dialysate are summarized in this paper. Production of ultrapure dialysate may be achieved on a routine basis, provided adequate components are used, and hygienic handling is regularly ensured. It includes the use of ultrapure water, clean and or sterile electrolytic concentrates (liquid or powder), implementation of ultrafilters on hemodialysis machines, microbiologic monitoring and hygienic handling of the chain with frequent disinfection. Safety and reliability of ultrapure dialysate production relies on a continuous quality assurance process, where results are coupled to corrective action in a feedback loop process. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:200 / 213
页数:14
相关论文
共 78 条
[1]   THE EFFECTS OF ENDOTOXIN-CONTAMINATED DIALYSATE AND POLYSULFONE OR CELLULOSIC MEMBRANES ON THE RELEASE OF TNF-ALPHA DURING SIMULATED DIALYSIS [J].
ARDUINO, MJ ;
BLAND, LA ;
MCALLISTER, SK ;
FAVERO, MS .
ARTIFICIAL ORGANS, 1995, 19 (09) :880-886
[2]   COMPARISON OF MICROBIOLOGIC ASSAY-METHODS FOR HEMODIALYSIS FLUIDS [J].
ARDUINO, MJ ;
BLAND, LA ;
AGUERO, SM ;
CARSON, L ;
RIDGEWAY, M ;
FAVERO, MS .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (03) :592-594
[3]   EFFECTS OF INCUBATION-TIME AND TEMPERATURE ON MICROBIOLOGIC SAMPLING PROCEDURES FOR HEMODIALYSIS FLUIDS [J].
ARDUINO, MJ ;
BLAND, LA ;
AGUERO, SM ;
FAVERO, MS .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (07) :1462-1465
[4]  
Arvanitidou M, 1999, J NEPHROL, V12, P32
[5]   Contamination of dialysis water and dialysate: A survey of 30 centers [J].
Bambauer, R. ;
Schauer, M. ;
Jung, W.K. ;
Daum, V. ;
Vienken, J. .
ASAIO Journal, 1994, 40 (04) :1012-1016
[6]   BACTERIA-FREE AND ENDOTOXIN-FREE DIALYSIS FLUID FOR USE IN CHRONIC-HEMODIALYSIS [J].
BAMBAUER, R ;
WALTHER, J ;
MEYER, S ;
OST, S ;
SCHAUER, M ;
JUNG, WK ;
GOHL, H ;
VIENKEN, J .
ARTIFICIAL ORGANS, 1994, 18 (03) :188-192
[7]   ULTRAFILTRATION OF DIALYSIS FLUID TO OBTAIN A STERILE SOLUTION DURING HEMODIALYSIS [J].
BAMBAUER, R ;
WALTHER, J ;
JUNG, WK .
BLOOD PURIFICATION, 1990, 8 (06) :309-317
[8]  
BAMBAUER R, 1990, ASAIO T, V36, P317
[9]   USING ULTRAPURE WATER IN HEMODIALYSIS DELAYS CARPAL-TUNNEL SYNDROME [J].
BAZ, M ;
DURAND, C ;
RAGON, A ;
JABER, K ;
ANDRIEU, D ;
MERZOUK, T ;
PURGUS, R ;
OLMER, M ;
REYNIER, JP ;
BERLAND, Y .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (11) :681-685
[10]   OUTBREAK OF GRAM-NEGATIVE BACTEREMIA AND PYROGENIC REACTIONS IN A HEMODIALYSIS CENTER [J].
BECKSAGUE, CM ;
JARVIS, WR ;
BLAND, LA ;
ARDUINO, MJ ;
AGUERO, SM ;
VEROSIC, G .
AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (05) :397-403